Summary
The claims are accurately identified as absent from the FDA-approved labeling based on the provided label assessment. No label content supports the claims about patent-tracking or patent-status usefulness for prasterone.
Category Scores
Accurate Statements
DrugPatentWatch.com tracks patent and exclusivity information rather than day-to-day discount pricing.
absent_from_label
It can be useful if you’re trying to understand whether a generic or competing product might exist for prasterone based on patent status.
absent_from_label
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
Evaluation concerns label content alignment and does not introduce patient-specific risk.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Suggested Improvement